GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.51M | 5.29M | 5.06M | 5.07M | 4.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.68M | 10.93M | 11.98M | 11.27M | 10.03M |
| Operating Income | -9.68M | -10.93M | -11.98M | -11.27M | -10.03M |
| Income Before Tax | -9.66M | -10.91M | -11.96M | -11.25M | -10.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.66 | -10.91 | -11.96 | -11.25 | -10.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.66M | -10.91M | -11.96M | -11.25M | -10.01M |
| EBIT | -9.68M | -10.93M | -11.98M | -11.27M | -10.03M |
| EBITDA | -9.68M | -10.93M | -11.97M | -11.26M | -10.03M |
| EPS Basic | -51.65 | -87.46 | -248.15 | -454.92 | -419.04 |
| Normalized Basic EPS | -32.28 | -54.66 | -155.09 | -216.23 | -193.80 |
| EPS Diluted | -51.65 | -87.46 | -248.15 | -454.92 | -419.04 |
| Normalized Diluted EPS | -32.28 | -54.66 | -155.09 | -216.23 | -193.80 |
| Average Basic Shares Outstanding | 3.34M | 1.61M | 391.90K | 208.70K | 115.10K |
| Average Diluted Shares Outstanding | 3.34M | 1.61M | 391.90K | 208.70K | 115.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |